Literature DB >> 16840779

Identification of human STAT5-dependent gene regulatory elements based on interspecies homology.

Erik A Nelson1, Sarah R Walker, Wei Li, X Shirley Liu, David A Frank.   

Abstract

STAT5 is a transcription factor essential for hematopoietic physiology. STAT5 functions to transduce signals from cytokines to the nucleus where it regulates gene expression. Although several important transcriptional targets of STAT5 are known, most remain unidentified. To identify novel STAT5 targets, we searched chromosomes 21 and 22 for clusters of STAT5 binding sites contained within regions of interspecies homology. We identified four such regions, including one with tandem STAT5 binding sites in the first intron of the NCAM2 gene. Unlike known STAT5 binding sites, this site is found within a very large intron and resides approximately 200 kb from the first coding exon of NCAM2. We demonstrate that this region confers STAT5-dependent transcriptional activity. We show that STAT5 binds in vivo to the NCAM2 intron in the NKL natural killer cell line and that this binding is induced by cytokines that activate STAT5. Neither STAT1 nor STAT3 bind to this region, despite sharing a consensus binding sequence with STAT5. Activation of STAT4 and STAT5 causes the accumulation of both of these STATs to the NCAM2 regulatory region. Therefore, using an informatics based approach to identify STAT5 targets, we have identified NCAM2 as both a STAT4- and STAT5-regulated gene, and we show that its expression is regulated by cytokines essential for natural killer cell survival and differentiation. This strategy may be an effective way to identify functional binding regions for transcription factors with known cognate binding sites anywhere in the genome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16840779      PMCID: PMC3427032          DOI: 10.1074/jbc.M605001200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.

Authors:  T A Fehniger; M H Shah; M J Turner; J B VanDeusen; S P Whitman; M A Cooper; K Suzuki; M Wechser; F Goodsaid; M A Caligiuri
Journal:  J Immunol       Date:  1999-04-15       Impact factor: 5.422

2.  Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression.

Authors:  G B Udy; R P Towers; R G Snell; R J Wilkins; S H Park; P A Ram; D J Waxman; H W Davey
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

3.  Reduced expression of neural cell adhesion molecule induces metastatic dissemination of pancreatic beta tumor cells.

Authors:  A K Perl; U Dahl; P Wilgenbus; H Cremer; H Semb; G Christofori
Journal:  Nat Med       Date:  1999-03       Impact factor: 53.440

Review 4.  GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression.

Authors:  T Decker; P Kovarik; A Meinke
Journal:  J Interferon Cytokine Res       Date:  1997-03       Impact factor: 2.607

5.  Interaction of STAT5 dimers on two low affinity binding sites mediates interleukin 2 (IL-2) stimulation of IL-2 receptor alpha gene transcription.

Authors:  W K Meyer; P Reichenbach; U Schindler; E Soldaini; M Nabholz
Journal:  J Biol Chem       Date:  1997-12-12       Impact factor: 5.157

6.  The significance of tetramerization in promoter recruitment by Stat5.

Authors:  S John; U Vinkemeier; E Soldaini; J E Darnell; W J Leonard
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

7.  Loss of neural cell adhesion molecule induces tumor metastasis by up-regulating lymphangiogenesis.

Authors:  Ivana Crnic; Karin Strittmatter; Ugo Cavallaro; Lucie Kopfstein; Lotta Jussila; Kari Alitalo; Gerhard Christofori
Journal:  Cancer Res       Date:  2004-12-01       Impact factor: 12.701

8.  p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response.

Authors:  E Pfitzner; R Jähne; M Wissler; E Stoecklin; B Groner
Journal:  Mol Endocrinol       Date:  1998-10

9.  A sequence of the CIS gene promoter interacts preferentially with two associated STAT5A dimers: a distinct biochemical difference between STAT5A and STAT5B.

Authors:  F Verdier; R Rabionet; F Gouilleux; C Beisenherz-Huss; P Varlet; O Muller; P Mayeux; C Lacombe; S Gisselbrecht; S Chretien
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

10.  Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation.

Authors:  M Onishi; T Nosaka; K Misawa; A L Mui; D Gorman; M McMahon; A Miyajima; T Kitamura
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

View more
  12 in total

1.  Indirubin derivatives induce apoptosis of chronic myelogenous leukemia cells involving inhibition of Stat5 signaling.

Authors:  Sangkil Nam; Anna Scuto; Fan Yang; Wenyong Chen; Sungman Park; Hwa-Seung Yoo; Heiko Konig; Ravi Bhatia; Xinlai Cheng; Karl-Heinz Merz; Gerhard Eisenbrand; Richard Jove
Journal:  Mol Oncol       Date:  2012-02-17       Impact factor: 6.603

2.  Dispersed Chromosomal Stat5b-binding elements mediate growth hormone-activated insulin-like growth factor-I gene transcription.

Authors:  Dennis J Chia; Ben Varco-Merth; Peter Rotwein
Journal:  J Biol Chem       Date:  2010-04-07       Impact factor: 5.157

3.  Targeting STAT5 in hematologic malignancies through inhibition of the bromodomain and extra-terminal (BET) bromodomain protein BRD2.

Authors:  Suhu Liu; Sarah R Walker; Erik A Nelson; Robert Cerulli; Michael Xiang; Patricia A Toniolo; Jun Qi; Richard M Stone; Martha Wadleigh; James E Bradner; David A Frank
Journal:  Mol Cancer Ther       Date:  2014-01-16       Impact factor: 6.261

4.  Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3.

Authors:  Erik A Nelson; Sarah R Walker; Alicia Kepich; Laurie B Gashin; Teru Hideshima; Hiroshi Ikeda; Dharminder Chauhan; Kenneth C Anderson; David A Frank
Journal:  Blood       Date:  2008-09-29       Impact factor: 22.113

Review 5.  STAT5 in hematopoietic stem cell biology and transplantation.

Authors:  Zhengqi Wang; Kevin D Bunting
Journal:  JAKSTAT       Date:  2013-11-19

6.  Huntingtin modulates transcription, occupies gene promoters in vivo, and binds directly to DNA in a polyglutamine-dependent manner.

Authors:  Caroline L Benn; Tingting Sun; Ghazaleh Sadri-Vakili; Karen N McFarland; Derek P DiRocco; George J Yohrling; Timothy W Clark; Bérengère Bouzou; Jang-Ho J Cha
Journal:  J Neurosci       Date:  2008-10-15       Impact factor: 6.167

7.  A genome-wide search for new imprinted genes in the human placenta identifies DSCAM as the first imprinted gene on chromosome 21.

Authors:  Laïla Allach El Khattabi; Stéphanie Backer; Amélie Pinard; Marie-Noëlle Dieudonné; Vassilis Tsatsaris; Daniel Vaiman; Luisa Dandolo; Evelyne Bloch-Gallego; Hélène Jammes; Sandrine Barbaux
Journal:  Eur J Hum Genet       Date:  2018-09-11       Impact factor: 4.246

8.  Zinc finger nuclease mediated knockout of ADP-dependent glucokinase in cancer cell lines: effects on cell survival and mitochondrial oxidative metabolism.

Authors:  Susan Richter; Shona Morrison; Tim Connor; Jiechuang Su; Cristin G Print; Ron S Ronimus; Sean L McGee; William R Wilson
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

9.  Mutant KRAS Downregulates the Receptor for Leukemia Inhibitory Factor (LIF) to Enhance a Signature of Glycolysis in Pancreatic Cancer and Lung Cancer.

Authors:  Suhu Liu; Helen I Gandler; Isidora Tošić; Darwin Q Ye; Zachary T Giaccone; David A Frank
Journal:  Mol Cancer Res       Date:  2021-04-30       Impact factor: 5.852

10.  Biochemical characterization of diverse Stat5b-binding enhancers that mediate growth hormone-activated insulin-like growth factor-I gene transcription.

Authors:  Ben Varco-Merth; Kasim Mirza; Damir T Alzhanov; Dennis J Chia; Peter Rotwein
Journal:  PLoS One       Date:  2012-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.